207 related articles for article (PubMed ID: 4081964)
61. Granulocyte transfusions in recovery of neutropenic rats from induced E. coli toxicemia.
Popovic V; Schaffer R; Popovic P
Exp Hematol; 1977 May; 5(3):166-70. PubMed ID: 326570
[TBL] [Abstract][Full Text] [Related]
62. [Prophylaxis of infections in granulocytopenic patients (author's transl].
Grañena A; Rozman C; Aranalde JM; Feliú E; García J; Marín P; Montserrat-Costa E; Ribas Mundo M; Matutes E
Sangre (Barc); 1979; 24(5B):857-67. PubMed ID: 524232
[No Abstract] [Full Text] [Related]
63. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
[TBL] [Abstract][Full Text] [Related]
64. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
Bodey GP
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
[TBL] [Abstract][Full Text] [Related]
65. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)].
Garau Alemany J
Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230
[No Abstract] [Full Text] [Related]
66. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
Pizzo PA
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
[TBL] [Abstract][Full Text] [Related]
67. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
Gaya H; Klastersky J; Schimpff SC; Tattersall MH
Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
[No Abstract] [Full Text] [Related]
68. Integrated management of bacteraemic shock in neutropenia.
Bannatyne RM; Cheung R
Anticancer Res; 1983; 3(4):233-4. PubMed ID: 6309069
[TBL] [Abstract][Full Text] [Related]
69. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
70. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
71. Early granulocyte transfusions in high risk febrile neutropenic patients.
Schweiz Med Wochenschr Suppl; 1983; 14():46-8. PubMed ID: 6361991
[TBL] [Abstract][Full Text] [Related]
72. Antithrombin III in the diagnosis of infection in febrile neutropenic patients.
Kibbler CC; Prentice HG; Noone P
J Clin Microbiol; 1988 Oct; 26(10):2206-8. PubMed ID: 3183007
[TBL] [Abstract][Full Text] [Related]
73. The evolution of antibiotic therapy for neutropenic patients.
Bodey GP
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2660-5. PubMed ID: 10068270
[TBL] [Abstract][Full Text] [Related]
74. Neutropenia and fever.
Hughes WT
Pediatr Infect Dis; 1983; 2(3 Suppl):S14-7. PubMed ID: 6866796
[No Abstract] [Full Text] [Related]
75. Antibiotics for the treatment of febrile children with neutropenia and cancer.
Rubin M; Pizzo PA
N Engl J Med; 1989 Apr; 320(14):939. PubMed ID: 2927469
[No Abstract] [Full Text] [Related]
76. Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient.
Rolston KV; Bodey GP
Curr Clin Top Infect Dis; 1993; 13():164-71. PubMed ID: 8397908
[No Abstract] [Full Text] [Related]
77. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
[TBL] [Abstract][Full Text] [Related]
78. Infection in neutropenia: Anti-endotoxin effect of polymyxin.
Bannatyne RM; Cheung R
Anticancer Res; 1982; 2(4):239-40. PubMed ID: 6293368
[No Abstract] [Full Text] [Related]
79. Stopping antibiotic therapy in neutropenic patients.
DiNubile MJ
Ann Intern Med; 1988 Feb; 108(2):289-92. PubMed ID: 3341657
[TBL] [Abstract][Full Text] [Related]
80. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
Hughes WT; Armstrong D; Bodey GP; Feld R; Mandell GL; Meyers JD; Pizzo PA; Schimpff SC; Shenep JL; Wade JC
J Infect Dis; 1990 Mar; 161(3):381-96. PubMed ID: 2179420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
